Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

Obesity is linked to 13 different cancers. Scientists have long known that losing weight can slash the risk of cancer, but ...

They were either given weekly exenatide injections or a placebo jab. At the end of the 96-week study those taking exenatide, sold under the brand Bydureon in the UK, saw no benefits compared to ...

The research explored a combination of two additional diabetes medications: dapagliflozin and exenatide. Scientists wanted to ...

Type 2 diabetes is a long-term condition where the body struggles to manage sugar levels in the blood. Normally, doctors start treatment with a medicine called metformin. Metformin helps the body ...

such as liraglutide and exenatide, may have anti-cancer benefits beyond weight loss. Article continues below Researchers first discovered that patients treated with weight-loss injections and ...

α-Glucosidase inhibitors 0.5 0.8 Weight neutral Frequent GI side effects, three times/day dosing, expensive Exenatide 0.5 1.0 Weight loss Injections, frequent GI side effects, expensive ...

AstraZeneca announced that the EC green-lighted the new formulation of the once-weekly type-2 diabetes injection, which will be marketed as Bydureon BCise (exenatide 2mg prolonged-release suspension).